Recruiting now
-
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
Phase 2 · 40 people · 7 sites in United States · Recruiting now
-
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 · 37 people · 7 sites in United States · Recruiting now
-
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Phase 2 · 26 people · 1 site in United States · Recruiting now
-
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · randomised · 134 people · 2 sites in United States · Recruiting now
-
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Phase 2 · randomised · 236 people · 1 site in China · Recruiting now
-
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer
Phase 2 · 197 people · 1 site in Italy · Recruiting now